Giant Cell Arteritis

Impact of the COVID-19 lockdown on the management and control of patients with GCA
Roman Praliaud, Helene Greigert, Maxime Samson, Marianne Zeller, Mathieu Boulin, Philip Bielefeld, André Ramon, Yves Cottin, Bernard Bonnotte

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e102; DOI: 10.1136/annrheumdis-2020-218360
Response to: ‘Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic’ by Lecler et al
Sara Monti, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e90; DOI: 10.1136/annrheumdis-2020-218634
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Augustin Lecler, Delphine Villeneuve, Catherine Vignal, Thomas Sené

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e89; DOI: 10.1136/annrheumdis-2020-218343
Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’
Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219463; DOI: 10.1136/annrheumdis-2020-219463
Response to: ‘Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’’ by Evangelatos et al
Kornelis SM van der Geest, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219477; DOI: 10.1136/annrheumdis-2020-219477
Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis
Sara Monti, Paolo Delvino, Elisa Bellis, Alessandra Milanesi, Fabio Brandolino, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1658-1659; DOI: 10.1136/annrheumdis-2020-217915
Response to: ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ by Comarmond et al
Alessandro Tomelleri, Silvia Sartorelli, Elena Marina Baldissera, Lorenzo Dagna, Corrado Campochiaro

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-219414; DOI: 10.1136/annrheumdis-2020-219414
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’
Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, Fanny Domont, Céline Hatte, Ségolène Toquet-Bouedec, Perrine Guillaume-Jugnot, Anne-Claire Desbois, Mathieu Vautier, Aude Rigolet, Yves Allenbach, Olivier Benveniste, David Saadoun, Patrice Cacoub

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-219407; DOI: 10.1136/annrheumdis-2020-219407
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed ‘window of opportunity’
Alessandro Giollo, Riccardo Bixio, Davide Gatti, Ombretta Viapiana, Luca Idolazzi, Christian Dejaco, Maurizio Rossini

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218830; DOI: 10.1136/annrheumdis-2020-218830
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Ryu Watanabe, Motomu Hashimoto

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-217995; DOI: 10.1136/annrheumdis-2020-217995

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages